Search Results 921-930 of 91015 for Metastasis
... metastatic DD liposarcoma that progressed on 1 or more prior systemic ... metastases are present; ≤ 5 × ULN if liver metastases are present. Total ...
Alisertib With or Without Fulvestrant in Treating Patients With Locally Advanced or Metastatic, Endocrine-Resistant Breast Cancer · Overview · Participation ...
... metastatic breast cancer. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or ...
... metastatic NSCLC with histologically confirmed (squamous or nonsquamous) KRASG12C mutation and histologically confirmed PD-L1 TPS ≥ 1%. - Cohort C: Has an ...
Bidirectional treatment for metastatic gastric cancer. When stomach cancer metastasizes, it most often spreads to the peritoneum. In the past, the prognosis for ...
... metastasis, cardiovascular diseases, VEGF , cell signaling, and related studies. ... Our lab has six main research projects, focusing on angiogenesis and its role ...
... Metastatic Vertebral Body Tumor(s) Rochester, MN. The purpose of this study is to evaluate treating painful metastatic lesions in vertebral bodies with ...
Description. Paclitaxel protein-bound injection is used to treat metastatic breast cancer (cancer that has already spread) after other treatments have ...
... metastatic breast cancer. The names of the study drugs involved in this ... A Study to Collect Clinical Data, Blood Samples, and Tissue Specimens from Patients ...
Patients with HER2 positive disease. More than 2 prior lines of chemotherapy for metastatic breast cancer. Untreated and/or uncontrolled brain metastases. Prior ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.